MedTrace Logo

Postoperative Supplemental Oxygen in Liver Transplantation

NCT02857855 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2023-01-12

No results posted yet for this study

Summary

The aim of this prospective randomized controlled trial is to evaluate the impact of high concentration supplemental postoperative oxygen therapy on short-term and long-term results of liver transplantation, particularly with respect to infections and biliary complications.

Conditions

Interventions

PROCEDURE

80% fraction of inspired oxygen for 6 postoperative hours

80% fraction of inspired oxygen delivered for 6 postoperative hours, either by a nonrebreathing facemask with a reservoir or by a respirator

PROCEDURE

28% fraction of inspired oxygen for 6 postoperative hours

28% fraction of inspired oxygen delivered for 6 postoperative hours, either by a Venturi facemask or by a respirator

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Michał Grąt, M.D., PhD. · Department of General, Transplant and Liver Surgery, Medical University of Warsaw

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-27
Primary Completion
2020-04-07
Completion
2025-04-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02857855 on ClinicalTrials.gov